Niraj Vasisht
Director/Board Member at INHIBITOR THERAPEUTICS, INC.
Net worth: 3 800 $ as of 29/04/2024
Profile
Niraj Vasisht is currently the Chairman & Chief Executive Officer at Avior Bio, Inc. and an Independent Director at Inhibitor Therapeutics, Inc. He previously worked as the Director-Microencapsulation at Southwest Research Institute from 1994 to 2005 and as the Chief Technical Officer & Senior Vice President at BioDelivery Sciences International, Inc. from 2005 to 2018.
Vasisht holds a doctorate degree from Rensselaer Polytechnic Institute, a graduate degree from the University of New Hampshire, and an undergraduate degree from the Indian Institute of Technology Kanpur.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 28/03/2024 | 50,000 ( 0.03% ) | 3 800 $ | 29/04/2024 |
Niraj Vasisht active positions
| Companies | Position | Start |
|---|---|---|
| INHIBITOR THERAPEUTICS, INC. | Director/Board Member | 12/12/2022 |
Avior Bio, Inc.
 Avior Bio, Inc. Pharmaceuticals: MajorHealth Technology Avior Bio, Inc. is a pharmaceutical company that specializes in innovative drug delivery and improved therapeutics. The company is based in Holly Springs, NC. The company's Technology Speedit™ Transmucosal Film Technology provides fast onset, enhanced permeation, reduced variability, and high bioavailability. Niraj Vasisht has been the CEO of the company since 2018. | Chief Executive Officer | 28/02/2018 |
Former positions of Niraj Vasisht
| Companies | Position | End |
|---|---|---|
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Chief Tech/Sci/R&D Officer | 03/02/2018 |
Southwest Research Institute
 Southwest Research Institute Miscellaneous Commercial ServicesCommercial Services Southwest Research Institute is a research and development organization. It offers technical services in engine design and development, emissions certification testing, fuels and lubricants. The firm provide services to automotive and transportation, biomedical and health, chemistry and materials, defence and security, electronics and automation, energy and environment, manufacturing and construction industries. The company was founded in 1947 and is headquartered in San Antonio, TX. | Corporate Officer/Principal | - |
Training of Niraj Vasisht
| Rensselaer Polytechnic Institute | Doctorate Degree |
| University of New Hampshire | Graduate Degree |
| Indian Institute of Technology Kanpur | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| INHIBITOR THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Southwest Research Institute
Southwest Research Institute Miscellaneous Commercial ServicesCommercial Services Southwest Research Institute is a research and development organization. It offers technical services in engine design and development, emissions certification testing, fuels and lubricants. The firm provide services to automotive and transportation, biomedical and health, chemistry and materials, defence and security, electronics and automation, energy and environment, manufacturing and construction industries. The company was founded in 1947 and is headquartered in San Antonio, TX. | Commercial Services |
Avior Bio, Inc.
Avior Bio, Inc. Pharmaceuticals: MajorHealth Technology Avior Bio, Inc. is a pharmaceutical company that specializes in innovative drug delivery and improved therapeutics. The company is based in Holly Springs, NC. The company's Technology Speedit™ Transmucosal Film Technology provides fast onset, enhanced permeation, reduced variability, and high bioavailability. Niraj Vasisht has been the CEO of the company since 2018. | Health Technology |
- Stock Market
- Insiders
- Niraj Vasisht
